| Application no. and date | 16205881.2 (espacenet) (Federated) (European Patent Register), 20110121 | | Patent/reg. no. and date | DK/EP 3216459, 20180926 | | Publication date | 20170913 | | Priority no. and date | EP 10305070, 20100121 | | EP pub. no. and date |
EP 3216459 20170913 | | Effective date | | | Applicant/owner | SANOFI, 54 rue La Boétie
75008 Paris, FR | | Applicant ref. no. | SAN DE2010/012-EP-EPT[3] | | Inventor | SCHAEFER, Hans-Ludwig, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
Sommerfeld, Mark, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
Boscheinen, Oliver, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
Dreyer, Matthias, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
RAO, Ercole, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
Habermann, Paul, -
deceased, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/18 (2006.01) , A61K 38/26 (2006.01) , A61P 3/00 (2006.01) | | Title | Farmaceutisk præparat til behandling af et metabolisk syndrom | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
